Science & Technology
Paley Rothman’s experienced attorneys are uniquely capable of providing today’s technology-based companies with the diverse legal services they require. Our attorneys take a practical problem-solving approach to transactions and negotiations, and we understand the business challenges faced by high-tech clients. We take care to stay abreast of changes and developments in technology licensing and transactions, E-commerce and Internet law, and corporate finance for early-stage businesses. Paley Rothman’s Science and Technology practice group also handles large-scale real estate transactions for technology firms, including highly specialized transactions for biotech companies.
Paley Rothman’s attorneys have negotiated virtually every type of domestic and international licensing agreement on behalf of both licensors and licensees in information technology, pharmaceuticals and biotechnology, as well as many other technology sectors. Many of these licenses are vital parts of broader domestic or international business transactions including toll manufacturing agreements, supply agreements and distribution arrangements. We also routinely establish general and project-specific joint ventures and prepare research and development and related agreements and partnerships, including specialized agreements for electronic game development, design and distribution.
Our attorneys negotiate and draft complex licenses and contracts with clients and service providers for online businesses. Our clients include application service providers, database licensors and virtually all types of professional service firms that deliver services or value-added information to clients through the Internet. We advise clients on E-commerce issues of all types, including disputes over domain names and websites, and we negotiate and litigate these issues when necessary. We also monitor judicial and legislative developments affecting the Internet, such as limits on transmission of copyrighted audio and video, the developing law of online privacy, initiatives relating to identity theft, the Children’s Online Privacy Protection Act, the Electronic Funds Transfer Act, the Uniform Electronic Transactions Act (authorizing use of electronic “signatures”) and many others.
Technology companies cannot survive unless their proprietary technologies are well protected. Paley Rothman’s attorneys frequently prepare specialized confidentiality and non-disclosure agreements, including consulting and employment agreements, which contain measures to protect the value of intellectual property after the end of the relationship. We regularly advise clients on disputes arising from alleged misappropriation of trade secrets and also create defensible, yet practical corporate procedures and guidelines for in-house management of confidential information.
When it comes to attracting the attention of clients and protecting or increasing market share, Paley Rothman understands that a firm’s trademarks are often as valuable as its products and services. We also recognize that copyright registration affords important advantages in protecting against appropriation of valuable intellectual property. Attorneys in the Science and Technology practice group prepare and prosecute trademark applications and work with clients to structure cost-effective copyright registration programs. Our attorneys also counsel clients when disputes arise and have successfully litigated infringement cases to conclusion when needed.
Our experience with many specialized regulatory and licensing requirements as well as with federal, state and local grants and benefits allows us to help clients establish tax-advantaged business organizations that optimally fit their unique needs. This enables us to form and represent technology-based entities ranging from fast-growth startup companies to fully mature regional and national companies. We handle syndications, venture capital placements, leveraged acquisitions and other forms of financing, often working closely with clients to refine business plans in preparation for negotiations with lenders and investors.
Paley Rothman represents major biotechnology, pharmaceutical and chemical manufacturing firms, including several Fortune 500 companies, in the Washington, D.C. metropolitan area, nationally and internationally. Our services include pharmaceutical licensing, regulatory compliance, FIFRA counseling, and structuring and closing synthetic lease financings for cGMP manufacturing facilities and R & D campuses.
May 17, 2022
Paley Rothman Employment Law Chair, Jim Hammerschmidt will be hosting MCSHRM's 2022 Employment Law Update - MD, VA & DC. This event will start on June 15, 2022 at 7:30 AM EST.Read More
Continuing our celebration of inspiring Asian American figures for Asian American and Pacific Islander (AAPI) Heritage Month, we bring you the story Dr. Bhagat Singh Thind.Read More
Paley Rothman is proud to announce that three of our distinguished attorneys were named 2022 Washingtonian Top Financial Advisers for the 3rd consecutive time amongst approximately 50 Top Estate Attorneys in the DC Metropolitan area. We are honored to have Jeffrey Kolender, Paula Calimafde, and Michelle Chapin in our sophisticated and caring estate planning and estate administration groups. Both groups are known for their familiarity with cutting edge techniques while providing exceptional service to our clients.
Paley Rothman is pleased to announce that 10 of the firm’s attorneys have been named Maryland Super Lawyers for 2022 and two have been selected as Rising Stars. Glenn Cooper has been ranked as a Maryland Super Lawyer Top 10 for the eighth consecutive year and has been on the Super Lawyers list for the past 15 years. Trish Weaver was also honored as one of Maryland's Top 50 Women Super Lawyers, a spot she has held four times in the last six years.
For the 10th year in a row, Paley Rothman earned national and local honors in U.S. News - Best Lawyers® 2022 “Best Law Firms” rankings.